Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Takeda Pharmaceutical Company Limited’s current trading price is -4.66% away from its 52-week high, while its distance from the 52-week low is 33.14%. The stock’s price range during this period has varied between $12.28 and $17.15. The company, active in the Healthcare sector, saw a trading volume of around 1.08 million for the day, considerably lower average daily volume of 2.12 million observed over the last three months.
Takeda Pharmaceutical Company Limited (TAK) currently has a stock price of $16.35. The stock saw a sharp increase in the last trading session, hitting a high of $15.99 after opening at $15.91. The lowest recorded price for the day was $15.90 before it closed at $15.96.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Takeda Pharmaceutical Company Limited’s stock has had a calm market performance. The 1-year high for the company’s stock was $17.15 on 04/06/23, and the lowest price during the same period was recorded at $12.28 on 10/21/22.
How Financial Performance Impacts Market Capitalization
Takeda Pharmaceutical Company Limited (TAK) has experienced a quarterly rise of 1.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.14B and boasts a workforce of 49095 employees.
Decoding Analysts’ Ratings for Takeda Pharmaceutical Company Limited
As of right now, 6 analysts are rating Takeda Pharmaceutical Company Limited as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 12 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.81, with a change in price of -0.49. Similarly, Takeda Pharmaceutical Company Limited recorded 2,059,084 in trading volume during the last 100 days, posting a change of -2.91%.
How TAK’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TAK stands at 0.69. Similarly, the long-term debt-to-equity ratio is also 0.63.
TAK Stock Stochastic Average
As of today, the raw stochastic average of Takeda Pharmaceutical Company Limited over the past 50 days is 100.00%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 100.00%. Additionally, the Stochastic %K and %D values for the company were 96.90% and 88.96%, respectively, over the past 20 days.
TAK Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 4.81%.However, over the last six months, we can see a weaker performance of 1.68%. Over the last 30 days, the price of TAK has fallen by 7.50%. And in the last five days, it has surged by 6.86%.
